Echinocandins: A ray of hope in antifungal drug therapy

Indian Journal of Pharmacology

Volumn 42, Issue 6, 2010, Pages 422-

  Grover, Neeta D ^a  

^a Bharati Vidyapeeth Deemed University Medical College and Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; MICAFUNGIN;

CANDIDIASIS; DRUG APPROVAL; DRUG INDICATION; DRUG MARKETING; DRUG SAFETY; HUMAN; INVASIVE CANDIDIASIS; LETTER; LIVER TOXICITY; PREMATURITY;

EID: 78149390369     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.71906     Document Type: Letter

References (7)

1. Gonzalez-Granado L. Very-low-birth-weight infants, prophylactic micafungin or fluconazole. Indian J Pharmacol 2010;42:422.
2. Grover ND. Echinocandins: A ray of hope in antifungal drug therapy. Indian J Pharmacol 2010;42:9-11.
3. Mycamine.Summary of Product Characteristics as provided by Astellas Pharma Ltd. Available from: http://www.emc.medicines.org.uk [last updated on 2009 Dec 3]. [last accessed on 2010 Apr 26].
4. European Medicines Agency. Mycamine European Public Assessment Report: Scientific discussion; April 2008. Available from: http://www.emea.europa.eu [last accessed on 2010 Apr 26].
5. Pappas G, Lerodiakonou V, Falagas ME. Lost in translation: Differences in antimicrobial indication approval policies between the United States and Europe. Clin Ther 2009;31:1595-603.
6. Carter NJ, Keating GM. Micafungin: A review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients. Pediatr Drugs 2009;11:271-91
7. King KY, Edwards MS, Word BM. Hepatitis associated with micafungin use in a preterm infant. J Perinatol 2009;29:320-2.